Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-06-07 06:18 am Purchase | 13G | Galera Therapeutics Inc. GRTX | HIRSCHMAN ORIN | 2,095,291 11% | 358,969 (+20.67%) | View |
2021-05-28 4:06 pm Sale | 13G | MYOMO INC. MYO | HIRSCHMAN ORIN | 279,641 4.99% | -153,928 (-35.50%) | View |
2021-05-26 06:21 am Sale | 13G | LIGHTPATH TECHNOLOGIES INC LPTH | HIRSCHMAN ORIN | 0 0% | -1,854,324 (Position Closed) | View |
2021-05-06 4:20 pm Purchase | 13G | EVOKE PHARMA INC EVOK | HIRSCHMAN ORIN | 1,701,185 5.3% | 268,072 (+18.71%) | View |
2021-04-29 6:19 pm Purchase | 13G | Galera Therapeutics Inc. GRTX | HIRSCHMAN ORIN | 1,736,322 11% | 1,736,322 (New Position) | View |
2021-04-16 4:07 pm Sale | 13G | NUVVE HOLDING CORP. COM NVVE | HIRSCHMAN ORIN | 717,916 11% | -802,084 (-52.77%) | View |
2021-04-06 06:39 am Purchase | 13G | NUVVE HOLDING CORP. COM NVVE | HIRSCHMAN ORIN | 1,520,000 11% | 1,520,000 (New Position) | View |
2021-03-25 6:28 pm Sale | 13G | EVOKE PHARMA INC EVOK | HIRSCHMAN ORIN | 1,433,113 4.4% | -266,887 (-15.70%) | View |
2021-03-17 4:10 pm Sale | 13G | NLS PHARMACEUTICS LTD WT PUR C NLSPW | HIRSCHMAN ORIN | 577,185 4.9% | -342,815 (-37.26%) | View |
2021-03-17 4:06 pm Sale | 13G | ACER THERAPEUTICS INC. ACER | HIRSCHMAN ORIN | 0 0% | -982,446 (Position Closed) | View |
2021-02-22 07:18 am Purchase | 13G | Adamas Pharmaceuticals Inc ADMS | HIRSCHMAN ORIN | 1,611,313 11% | 1,611,313 (New Position) | View |
2021-02-11 7:15 pm Sale | 13G | Salarius Pharmaceuticals Inc. SLRX | HIRSCHMAN ORIN | 1,166,619 4.99% | -50,771 (-4.17%) | View |
2021-02-11 6:25 pm Sale | 13G | CYCLO THERAPEUTICS INC CYTH | HIRSCHMAN ORIN | 209,383 4.99% | -208,617 (-49.91%) | View |
2021-02-10 4:26 pm Purchase | 13G | NANOVIBRONIX INC NAOV | HIRSCHMAN ORIN | 771,462 3.9% | 341,795 (+79.55%) | View |
2021-02-10 4:23 pm Purchase | 13G | MYOMO INC. MYO | HIRSCHMAN ORIN | 433,569 9.5% | 17,510 (+4.21%) | View |
2021-02-10 4:21 pm Purchase | 13G | LIGHTPATH TECHNOLOGIES INC LPTH | HIRSCHMAN ORIN | 1,854,324 7.1% | 20,193 (+1.10%) | View |
2021-02-10 4:18 pm Purchase | 13G | ALIMERA SCIENCES INC ALIM | HIRSCHMAN ORIN | 501,025 11% | 28,000 (+5.92%) | View |
2021-02-10 4:13 pm Unchanged | 13G | ACER THERAPEUTICS INC. ACER | HIRSCHMAN ORIN | 982,446 11% | 0 (Unchanged) | View |
2021-02-10 2:36 pm Purchase | 13G | EMCORE CORP EMKR | HIRSCHMAN ORIN | 2,310,364 7.8% | 331,351 (+16.74%) | View |
2021-02-09 5:06 pm Sale | 13G | ENERGY FOCUS INC PAR $0.00 EFOI | HIRSCHMAN ORIN | 0 0% | -1,500,000 (Position Closed) | View |